"Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the deal," said one of the two sources cited above.Samara Capital likely to buy Novartis brands
"Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the deal," said one of the two sources cited above.
0 коммент.:
Отправить комментарий